SCLX PEER ANALYSIS

Scilex Holding Company — metric-by-metric comparison with peers and the industry median

SCLXScilex Holding Company

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

SCLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SCLX	ANGEN	HIK	LKMNH	MEDTR	RTALB	Ind. Median
P/E	—	—	11.43	22.46	596.83	4.89●	23.37
P/B	-0.22●	1.32	1.78	1.16	1.08	0.61	4.60
EV/EBITDA	—	34.77	8.74	4.65●	10.93	74.61	13.81
P/S	1.59	2.95	1.37	0.71●	1.18	6.67	3.25

Financial Health
Metric	SCLX	ANGEN	HIK	LKMNH	MEDTR	RTALB	Ind. Median
Current Ratio	0.08	2.31	1.82	0.83	3.58●	1.21	1.25
Debt/Equity	-42.7%●	28.1%	61.8%	99.0%	1.0%	1.2%	94.3%
NetDebt/EBITDA	-0.31	4.71	1.87	1.96	-1.64●	0.90	1.35

Profitability
Metric	SCLX	ANGEN	HIK	LKMNH	MEDTR	RTALB	Ind. Median
Net Margin	-1,239.4%	-45.0%	12.0%	3.2%	0.2%	136.3%●	15.0%
ROE	—	-21.0%	16.4%●	5.6%	0.2%	15.1%	23.7%
ROA	-225.3%	-15.7%	7.5%	2.7%	0.2%	13.1%●	8.0%
EBITDA Margin	-984.4%	9.8%	20.0%	26.4%●	9.4%	9.0%	28.4%

Growth + Dividend
Metric	SCLX	ANGEN	HIK	LKMNH	MEDTR	RTALB	Ind. Median
Rev. Growth	-33.2%	11.7%	7.4%	19.8%	6.5%	24.0%●	3.3%
NI Growth	—	—	12.2%	-44.2%	-62.9%	134.0%●	32.9%
Div. Yield	1.0%	0.0%	5.4%●	3.6%	1.1%	0.0%	2.1%
Payout	-0.1%	0.0%	45.2%	81.3%	656.3%	0.0%	45.7%

Valuation
Metric	SCLX	DCGO	LUNG	PDSB	PMVP	VRCA	Ind. Median
P/E	—	—	—	—	—	—	23.37
P/B	-0.22●	0.41	1.27	12.16	0.74	4.07	4.60
EV/EBITDA	—	—	—	—	—	—	13.81
P/S	1.59	0.18●	0.66	—	—	1.76	3.25

Financial Health
Metric	SCLX	DCGO	LUNG	PDSB	PMVP	VRCA	Ind. Median
Current Ratio	0.08	1.79	4.91	2.26	11.14●	2.02	1.25
Debt/Equity	-42.7%●	21.5%	123.0%	407.5%	0.3%	9.0%	94.3%
NetDebt/EBITDA	-0.31●	0.05	0.11	0.21	1.19	1.69	1.35

Profitability
Metric	SCLX	DCGO	LUNG	PDSB	PMVP	VRCA	Ind. Median
Net Margin	-1,239.4%	-62.2%	-60.1%	—	—	-48.0%●	15.0%
ROE	—	-85.0%	-86.2%	-254.1%	-63.2%●	—	23.7%
ROA	-225.3%	-58.7%	-39.3%●	-93.1%	-58.6%	-44.0%	8.0%
EBITDA Margin	-984.4%	-51.8%	-54.5%	—	—	-30.6%●	28.4%

Growth + Dividend
Metric	SCLX	DCGO	LUNG	PDSB	PMVP	VRCA	Ind. Median
Rev. Growth	-33.2%	-42.0%	1.2%	-100.0%	—	417.6%●	3.3%
NI Growth	—	—	—	—	—	—	32.9%
Div. Yield	1.0%	—	—	—	—	—	2.1%
Payout	-0.1%	—	—	—	—	—	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SCLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.